|
|
|
National Stock Number:
6505-01-073-1552
Federal Supply Class:
6505
National Item Identification Number:
010731552
Description:
THEOPHYLLINE EXTENDED-RELEASE TA
|
Manufacturer Information:
| NDC00085-0584-81 | 1F095 | SCHERING-PLOUGH CORPORATION | | NDC00182-1400-89 | 0LXM4 | IVAX | | NDC00258-3581-01 | 6X308 | INWOOD LABORATORIES INC | | NDC00369-0803-81 | 24214 | KEY PHARMACEUTICALS INC | | NDC00456-4330-01 | 65050 | FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC | | NDC00603-5946-21 | 0ET99 | GENERICS BIDCO I, LLC | | NDC00677-0817-01 | 59225 | BAXTER HEALTHCARE CORP BAXTER AIRLIFE/PHARMASEAL DIV | | NDC00904-1612-61 | 0SYT3 | MAJOR PHARMACEUTICALS INC | | NDC50111-0459-01 | 3PYX2 | PLIVA INC. | | NDC61570-0019-01 | 09GL2 | MONARCH PHARMACEUTICALS INC | | THEO-DUR | 1F095 | SCHERING-PLOUGH CORPORATION | | THEO-DUR | 24214 | KEY PHARMACEUTICALS INC |
|
Techincal Specification:
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT | | FEATURES PROVIDED | UNIT DOSE | | PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG | | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS | | PRIMARY CONTAINER TYPE | STRIP | | THERAPEUTIC EQUIVALENT | THEO-DUR BY KEY PHARM |
|